Safety of Maitake D-Fraction in Healthy Patients: Assessment of Common Hematologic Parameters
2004; Mary Ann Liebert, Inc.; Volume: 10; Issue: 4 Linguagem: Inglês
10.1089/1076280041580341
ISSN1557-9085
AutoresSmadelli Glauco, Freddo Jano, Giordo Paolo, Sensuke Konno,
Tópico(s)Liver Disease Diagnosis and Treatment
ResumoAlternative and Complementary TherapiesVol. 10, No. 4 ArticlesSafety of Maitake D-Fraction in Healthy Patients: Assessment of Common Hematologic ParametersSmadelli Glauco, Freddo Jano, Giordo Paolo, and Sensuke KonnoSmadelli GlaucoSearch for more papers by this author, Freddo JanoSearch for more papers by this author, Giordo PaoloSearch for more papers by this author, and Sensuke KonnoSearch for more papers by this authorPublished Online:25 Aug 2004https://doi.org/10.1089/1076280041580341AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byBioactive polysaccharides from medicinal mushrooms: A review on their isolation, structural characteristics and antitumor activityFood Bioscience, Vol. 49Antitumor activities of Grifola frondosa (Maitake) polysaccharide: A meta-analysis based on preclinical evidence and quality assessmentJournal of Ethnopharmacology, Vol. 280SX-fraction: Promise for novel treatment of type 2 diabetesWorld Journal of Diabetes, Vol. 11, No. 12The biological activities of the antitumor drug Grifola frondosa polysaccharideAntitumoral and antimetastatic activity of Maitake D-Fraction in triple-negative breast cancer cells10 April 2018 | Oncotarget, Vol. 9, No. 34Polysaccharides in Grifola frondosa mushroom and their health promoting properties: A reviewInternational Journal of Biological Macromolecules, Vol. 101Safety assessment of mushrooms in dietary supplements by combining analytical data with in silico toxicology evaluationFood and Chemical Toxicology, Vol. 103Improved Anticancer Effects on Various Cancers with Combinations of Chemotherapeutic Drugs or Vitamin C and D-FractionJournal of Cancer Therapy, Vol. 04, No. 04Commonly consumed and specialty dietary mushrooms reduce cellular proliferation in MCF-7 human breast cancer cells1 November 2010 | Experimental Biology and Medicine, Vol. 235, No. 11El hongo maitake (Grifola frondosa) y su potencial terapéuticoRevista Iberoamericana de Micología, Vol. 25, No. 3 Volume 10Issue 4Aug 2004 Information© 2004 Mary Ann Liebert, Inc.To cite this article:Smadelli Glauco, Freddo Jano, Giordo Paolo, and Sensuke Konno.Safety of Maitake D-Fraction in Healthy Patients: Assessment of Common Hematologic Parameters.Alternative and Complementary Therapies.Aug 2004.228-230.http://doi.org/10.1089/1076280041580341Published in Volume: 10 Issue 4: August 25, 2004PDF download
Referência(s)